McIntyre R, Berk M, Brietzke E, Goldstein B, López-Jaramillo C, Kessing L, et al. Bipolar disorders. Lancet. 2020;396:1841–56.

Article  CAS  PubMed  Google Scholar 

Craddock N, Sklar P. Genetics of bipolar disorder. Lancet. 2013;381:1654–62.

Article  CAS  PubMed  Google Scholar 

Ludwig B, Dwivedi Y. Dissecting bipolar disorder complexity through epigenomic approach. Mol psychiatry. 2016;21:1490–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lan M, McLoughlin G, Griffin J, Tsang T, Huang J, Yuan P, et al. Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Mol psychiatry. 2009;14:269–79.

Article  CAS  PubMed  Google Scholar 

Wang Y, Sun K, Liu Z, Chen G, Jia Y, Zhong S, et al. Classification of unmedicated bipolar disorder using whole-brain functional activity and connectivity: a radiomics analysis. Cereb cortex. 2020;30:1117–28.

Article  PubMed  Google Scholar 

Drago A, Crisafulli C, Calabrò M, Serretti A. Enrichment pathway analysis. The inflammatory genetic background in Bipolar Disorder. J Affect Disord. 2015;179:88–94.

Article  PubMed  Google Scholar 

Fernandes B, Steiner J, Molendijk M, Dodd S, Nardin P, Gonçalves C, et al. C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis. Lancet Psychiatry. 2016;3:1147–56.

Article  PubMed  Google Scholar 

Wu W, Zheng YL, Tian LP, Lai JB, Hu CC, Zhang P, et al. Circulating T lymphocyte subsets, cytokines, and immune checkpoint inhibitors in patients with bipolar II or major depression: a preliminary study. Sci Rep. 2017;7:40530.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barbosa I, Rocha N, Assis F, Vieira É, Soares J, Bauer M, et al. Monocyte and lymphocyte activation in bipolar disorder: a new piece in the puzzle of immune dysfunction in mood disorders. Int J Neuropsychopharmacol. 2014;18:021.

Google Scholar 

Berk M, Kapczinski F, Andreazza A, Dean O, Giorlando F, Maes M, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 2011;35:804–17.

Article  CAS  PubMed  Google Scholar 

Morais L, Schreiber H, Mazmanian S. The gut microbiota-brain axis in behaviour and brain disorders. Nat Rev Microbiol. 2021;19:241–55.

Article  CAS  PubMed  Google Scholar 

Long-Smith C, O’Riordan KJ, Clarke G, Stanton C, Dinan TG, Cryan JF. Microbiota-gut-brain axis: new therapeutic opportunities. Annu Rev Pharmacol Toxicol. 2020;60:477–502.

Article  CAS  PubMed  Google Scholar 

Rios A, Maurya P, Pedrini M, Zeni-Graiff M, Asevedo E, Mansur R, et al. Microbiota abnormalities and the therapeutic potential of probiotics in the treatment of mood disorders. Rev Neurosci. 2017;28:739–49.

Article  PubMed  Google Scholar 

Abildgaard A, Elfving B, Hokland M, Wegener G, Lund S. Probiotic treatment reduces depressive-like behaviour in rats independently of diet. Psychoneuroendocrinology. 2017;79:40–8.

Article  CAS  PubMed  Google Scholar 

Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan J, Dinan T. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience. 2010;170:1179–88.

Article  CAS  PubMed  Google Scholar 

Zheng P, Zeng B, Zhou C, Liu M, Fang Z, Xu X, et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Mol Psychiatry. 2016;21:786–96.

Article  CAS  PubMed  Google Scholar 

Huang T, Lai J, Du Y, Xu Y, Ruan L, Hu S. Current Understanding of gut microbiota in mood disorders: an update of human studies. Front Genet. 2019;10:98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Borre Y, O’Keeffe G, Clarke G, Stanton C, Dinan T, Cryan J. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med. 2014;20:509–18.

Article  PubMed  Google Scholar 

Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998; 59(Suppl 20): 22–33;quiz 34–57.

Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–9.

Article  CAS  PubMed  Google Scholar 

Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429–35.

Article  CAS  PubMed  Google Scholar 

Bajaj J, Hylemon P, Ridlon J, Heuman D, Daita K, White M, et al. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol. 2010;303:675–85.

Article  Google Scholar 

Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil. 2010;22(512–519):e114-515.

Google Scholar 

Matera G, Muto V, Vinci M, Zicca E, Abdollahi-Roodsaz S, van de Veerdonk F, et al. Receptor recognition of and immune intracellular pathways for Veillonella parvula lipopolysaccharide. Clin Vaccine Immunol. 2009;16:1804–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Evans SJ, Bassis CM, Hein R, Assari S, Flowers SA, Kelly MB, et al. The gut microbiome composition associates with bipolar disorder and illness severity. J Psychiatr Res. 2017;87:23–9.

Article  PubMed  Google Scholar 

Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun. 2015;48:186–94.

Article  PubMed  Google Scholar 

Quévrain E, Maubert M, Michon C, Chain F, Marquant R, Tailhades J, et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease. Gut. 2016;65:415–25.

Article  PubMed  Google Scholar 

Tanca A, Abbondio M, Palomba A, Fraumene C, Manghina V, Cucca F, et al. Potential and active functions in the gut microbiota of a healthy human cohort. Microbiome. 2017;5(1):79.

Article  PubMed  PubMed Central  Google Scholar 

Leonel A, Alvarez-Leite J. Butyrate: implications for intestinal function. Curr Opin Clin Nutr Metab Care. 2012;15:474–9.

Article  CAS  PubMed  Google Scholar 

Yamawaki Y, Fuchikami M, Morinobu S, Segawa M, Matsumoto T, Yamawaki S. Antidepressant-like effect of sodium butyrate (HDAC inhibitor) and its molecular mechanism of action in the rat hippocampus. World J Biol Psychiatry. 2012;13:458–67.

Article  PubMed  Google Scholar 

Wei Y, Melas P, Wegener G, Mathé A, Lavebratt C. Antidepressant-like effect of sodium butyrate is associated with an increase in TET1 and in 5-hydroxymethylation levels in the Bdnf gene. Int J Neuropsychopharmacol. 2014;18:1.

Google Scholar 

Vital M, Howe A, Tiedje J. Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data. MBio. 2014;5:00889.

Article  Google Scholar 

Fernández J, Redondo-Blanco S, Gutiérrez-del-Río I, Miguélez EM, Villar CJ, Lombó F. Colon microbiota fermentation of dietary prebiotics towards short-chain fatty acids and their roles as anti-inflammatory and antitumour agents: a review. J Funct Foods. 2016;25:511–22.

Article  Google Scholar 

Colpo G, Leboyer M, Dantzer R, Trivedi M, Teixeira A. Immune-based strategies for mood disorders: facts and challenges. Expert Rev Neurother. 2018;18:139–52.

Article  CAS  PubMed  Google Scholar 

Painold A, Mörkl S, Kashofer K, Halwachs B, Dalkner N, Bengesser S, et al. A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode. Bipolar disord. 2019;21:40–9.

Article  CAS  PubMed  Google Scholar 

Crapser J, Ritzel R, Verma R, Venna V, Liu F, Chauhan A, et al. Ischemic stroke induces gut permeability and enhances bacterial translocation leading to sepsis in aged mice. Aging. 2016;8:1049–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Looft T, Levine U, Stanton T. Cloacibacillus porcorum sp. nov., a mucin-degrading bacterium from the swine intestinal tract and emended description of the genus Cloacibacillus. Int J Syst Evol Microbiol. 2013;63:1960–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bailey M, Dowd S, Galley J, Hufnagle A, Allen R, Lyte M. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav Immun. 2011;25:397–407.

Article  CAS  PubMed  Google Scholar 

Kverka M, Zakostelska Z, Klimesova K, Sokol D, Hudcovic T, Hrncir T, et al. Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol. 2011;163:250–9.